| Drug Name |
Ganciclovir sodium |
| Drug ID |
BADD_D01004 |
| Description |
An acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. |
| Indications and Usage |
For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients. |
| Marketing Status |
approved; investigational |
| ATC Code |
S01AD09; J05AB06 |
| DrugBank ID |
DB01004
|
| KEGG ID |
D04301
|
| MeSH ID |
D015774
|
| PubChem ID |
23700083
|
| TTD Drug ID |
D05ARP
|
| NDC Product Code |
46014-1054; 70436-089; 25021-185; 63323-315; 0143-9299; 51817-171; 0004-6941 |
| UNII |
02L083W284
|
| Synonyms |
Ganciclovir | Gancyclovir | BW-759 | Ganciclovir Sodium | Ganciclovir, Monosodium Salt | RS-21592 | BIOLF-62 | Cytovene |
